Kevin M Kalinsky

25PUBLICATIONS
259CO-AUTHORS
Models of care and place of birthHealth and ecological risk assessmentMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 29, 2026
Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women with HR+/HER2- Metastatic Breast Cancer.

Gregory A Vidal, Julie Katz, Natalia Sadetsky

|Nov 07, 2025
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.

Maxwell R Lloyd, Caroline M Weipert, Azka Ali

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Jun 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K.

Carolyn K McCourt, Zihan Wei, Kevin Kalinsky

|Jun 25, 2025
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.

Aditya Bardia, Hope S Rugo, Mina S Sedrak

|Apr 14, 2025
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer.

Junlong Jack Chi, Ping Xie, Mary Hongying Cheng

Pageof 5

Frequent Collaborators

8 joint publications

Hope S Rugo

6 joint publications

Aditya Bardia

6 joint publications

Melissa K Accordino

5 joint publications

Sara A Hurvitz